No picture, placeholder image
No picture, placeholder image
Førsteamanuensis Institutt for klinisk medisin khalid.i.al-shibli@uit.no

Khalid Ibrahim Al-Shibli



  • Khalid Ibrahim Al-Shibli, Hiba Abdul Latif Mohammed, Ramona Johansen Maurseth, Mikkel Fostervold, Sebastian Werner, Sveinung Sørbye :
    Impact of HPV mRNA types 16, 18, 45 detection on the risk of CIN3+ in young women with normal cervical cytology
    PLOS ONE 2022 DOI
  • Line Moi, Tonje Braaten, Khalid Al-Shibli, Eiliv Lund, Lill-Tove Rasmussen Busund :
    Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study
    Journal of Translational Medicine 2019 ARKIV / DOI
  • Jan Norum, Margaret Aarag Antonsen, Terje Tollåli, Khalid Al-Shibli, Gry Andersen, Kristin-Helene Svanqvist m.fl.:
    Pembrolizumab as second-line therapy in non-small cell lung cancer in northern Norway: budget impact and expected gain — a model-based analysis
    ESMO Open 2017 ARKIV / DOI
  • Sveinung Wergeland Sørbye, Pål Suhrke, Berit Wallem Revå, Jannicke Berland, Ramona Johansen Maurseth, Khalid Al-Shibli :
    Accuracy of cervical cytology: comparison of diagnoses of 100 Pap smears read by four pathologists at three hospitals in Norway
    BMC Clinical Pathology 2017 DOI
  • Tom Dønnem, Thomas Karsten Kilvær, Sigve Andersen, Elin Richardsen, Erna-Elise Paulsen, Sigurd Hald m.fl.:
    Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer
    Annals of Oncology 2016 DOI
  • Thomas Karsten Kilvær, Erna-Elise Paulsen, Mehrdad Rakaee, Samer Al-Saad, Ramona Johansen Maurseth, Khalid Al-Shibli m.fl.:
    The presence of intraepithelial CD45RO+ cells in resected lymph nodes with metastases from NSCLC patients is an independent predictor of disease-specific survival
    British Journal of Cancer 2016 ARKIV / DOI
  • Erna-Elise Paulsen, Thomas Karsten Kilvær, Mehrdad Rakaeekhanehkenari, Ramona Johansen Maurseth, Samer Al-Saad, Sigurd Hald m.fl.:
    CD45RO+ memory T lymphocytes – a candidate marker for TNM-immunoscore in squamous non-small cell lung cancer
    Neoplasia 2015 ARKIV / DOI
  • Carsten Nieder, Khalid Al-Shibli, Terje Tollåli :
    Nontargeted Effect after Radiotherapy in a Patient with Non-Small Cell Lung Cancer and Bullous Pemphigoid
    Case Reports in Oncological Medicine 2015 DOI
  • Tom Dønnem, Sigurd Hald, Erna-Elise Paulsen, Elin Richardsen, Samer Al-Saad, Thomas Karsten Kilvær m.fl.:
    Stromal CD8+ T-cell density - A promising supplement to TNM staging in non-small cell lung cancer
    Clinical Cancer Research 2015 DOI
  • Kaja Skjefstad, Elin Richardsen, Tom Dønnem, Sigve Andersen, Yury Kiselev, Thea Grindstad m.fl.:
    The prognostic role of progesterone receptor expression in non-small cell lung cancer patients: Gender-related impacts and correlation with disease-specific survival
    Steroids 2015 DOI
  • Sigurd Hald, Yury Kiselev, Samer Al-Saad, Elin Richardsen, Charles Johannessen, Marte Eilertsen m.fl.:
    Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: Combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival
    BMC Cancer 2015 ARKIV / DOI
  • Sigve Andersen, Elin Richardsen, Yngve Nordby, Nora Ness, Øystein Størkersen, Khalid Al-Shibli m.fl.:
    Disease-specific outcomes of Radical Prostatectomies in Northern Norway; A case for the impact of perineural infiltration and postoperative PSA-doubling time
    BMC Urology 2014 ARKIV / DOI
  • Marte Eilertsen, Sigve Andersen, Samer Al-Saad, Yury Kiselev, Tom Dønnem, Helge Stenvold m.fl.:
    Monocarboxylate transporters 1-4 in NSCLC: MCT1 is an independent prognostic marker for survival
    PLOS ONE 2014 ARKIV / DOI
  • Marte Eilertsen, Sigve Andersen, Samer Al-Saad, Elin Richardsen, Helge Stenvold, Sigurd Hald m.fl.:
    Positive prognostic impact of miR-210 in non-small cell lung cancer
    Lung Cancer 2014 DOI
  • Sveinung Wergeland Sørbye, Thomas Karsten Kilvær, Andrey Yurjevich Valkov, Tom Dønnem, Eivind Smeland, Khalid Al-Shibli m.fl.:
    Prognostic impact of Skp2, ER and PGR in male and female patients with soft tissue sarcomas
    BMC Clinical Pathology 15. mars 2013 FULLTEKST / ARKIV / DOI
  • Sigurd Hald, Roy M. Bremnes, Khalid Al-Shibli, Samer Al-Saad, Sigve Andersen, Helge Stenvold m.fl.:
    CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapy
    Lung Cancer 2013 ARKIV / DOI
  • Helge Stenvold, Tom Dønnem, Sigve Andersen, Samer Al-Saad, Khalid Ibrahim Al-Shibli, Lill-Tove Busund m.fl.:
    Overexpression of matrix metalloproteinase-7 and -9 in NSCLC tumor and stromal cells: Correlation with a favorable clinical outcome
    Lung Cancer 2012 DOI
  • Tom Dønnem, Christopher Graham Fenton, Kenneth Lønvik, Thomas Berg, Katrine Eklo, Sigve Andersen m.fl.:
    MicroRNA Signatures in Tumor Tissue Related to Angiogenesis in Non-Small Cell Lung Cancer
    PLOS ONE 2012 ARKIV / DOI
  • Sveinung Wergeland Sørbye, Thomas Karsten Kilvær, Andrey Yurjevich Valkov, Tom Dønnem, Eivind Smeland, Khalid Ibrahim Al-Shibli m.fl.:
    Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas
    BMC Clinical Pathology 03. mai 2012 FULLTEKST / ARKIV / DOI
  • Sveinung Wergeland Sørbye, Thomas Karsten Kilvær, Andrey Yurjevich Valkov, Tom Dønnem, Eivind Smeland, Khalid Ibrahim Al-Shibli m.fl.:
    Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomas
    BMC Clinical Pathology 29. februar 2012 FULLTEKST / ARKIV / DOI
  • Sveinung Wergeland Sørbye, Thomas Karsten Kilvær, Andrey Yurjevich Valkov, Tom Dønnem, Eivind Smeland, Khalid Al-Shibli m.fl.:
    Prognostic Impact of Jab1, p16, p21, p62, Ki67 and Skp2 in Soft Tissue Sarcomas
    PLOS ONE 2012 FULLTEKST / ARKIV / DOI
  • Roy M. Bremnes, Khalid Ibrahim Al-Shibli, Tom Dønnem, Rafael Sirera, Samer Al-Saad, Sigve Andersen m.fl.:
    The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis Emphasis on Non-small Cell Lung Cancer
    Journal of Thoracic Oncology 2011 DOI
  • Roy M. Bremnes, Tom Dønnem, Samer Al-Saad, Khalid Ibrahim Al-Shibli, Sigve Andersen, Rafael Sirera m.fl.:
    The Role of Tumor Stroma in Cancer Progression and Prognosis Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer
    Journal of Thoracic Oncology 2011 DOI
  • Sigve Andersen, Marte Eilertsen, Tom Dønnem, Khalid Ibrahim Al-Shibli, Samer Al-Saad, Lill-Tove Busund m.fl.:
    Diverging prognostic impacts of hypoxic markers according to NSCLC histology
    Lung Cancer 2011 DOI
  • Tom Dønnem, Katrine Eklo, Thomas Berg, Sveinung Wergeland Sørbye, Kenneth Lønvik, Samer Al-Saad m.fl.:
    Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization
    Journal of Translational Medicine 2011 ARKIV / DOI
  • Tom Dønnem, Kenneth Lønvik, Katrine Eklo, Thomas Berg, Sveinung Wergeland Sørbye, Khalid Ibrahim Al-Shibli m.fl.:
    Independent and Tissue-Specific Prognostic Impact of miR-126 in Nonsmall Cell Lung Cancer
    Cancer 2011 ARKIV / DOI
  • Sigve Andersen, Tom Dønnem, Khalid Ibrahim Al-Shibli, Samer Al-Saad, Helge Stenvold, Lill-Tove Busund m.fl.:
    Prognostic Impacts of Angiopoietins in NSCLC Tumor Cells and Stroma: VEGF-A Impact Is Strongly Associated with Ang-2
    PLOS ONE 2011 ARKIV / DOI
  • Tom Dønnem, Sigve Andersen, Samer Al-Saad, Khalid Ibrahim Al-Shibli, Lill-Tove Busund, Roy M. Bremnes :
    Prognostic Impact of Angiogenic Markers in Non-Small-Cell Lung Cancer is Related to Tumor Size
    Clinical Lung Cancer 2011 DOI
  • Sveinung Wergeland Sørbye, Thomas Karsten Kilvær, Andrey Yurjevich Valkov, Tom Dønnem, Eivind Smeland, Khalid Ibrahim Al-Shibli m.fl.:
    Prognostic Impact of Lymphocytes in Soft Tissue Sarcomas
    PLOS ONE 2011 ARKIV / DOI
  • Roy M. Bremnes, Khalid Ibrahim Al-Shibli, Tom Dønnem, Rafael Sirera, Samer Al-Saad, Sigve Andersen m.fl.:
    The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis
    Journal of Thoracic Oncology 2011 DOI
  • Sigve Andersen, Tom Dønnem, Helge Stenvold, Samer Al-Saad, Khalid Ibrahim Al-Shibli, Lill-Tove Busund m.fl.:
    Overexpression of the HIF Hydroxylases PHD1, PHD2, PHD3 and FIH Are Individually and Collectively Unfavorable Prognosticators for NSCLC Survival
    PLOS ONE 2011 ARKIV / DOI
  • Sigve Andersen, Tom Dønnem, Samer Al-Saad, Khalid Ibrahim Al-Shibli, Helge Stenvold, Lill-Tove Busund m.fl.:
    Correlation and Coexpression of HIFs and NOTCH Markers in NSCLC
    Anticancer Research 2011
  • Tom Dønnem, Sigve Andersen, Khalid Ibrahim Al-Shibli, Samer Al-Saad, Lill-Tove Rasmussen Busund, Roy M. Bremnes :
    Prognostic Impact of Notch Ligands and Receptors in Nonsmall Cell Lung Cancer Coexpression of Notch-1 and Vascular Endothelial Growth Factor-A Predicts Poor Survival
    Cancer 2010 DOI
  • Samer Al-Saad, Khalid Al-Shibli, Tom Dønnem, Sigve Andersen, Roy M. Bremnes, Lill-Tove Rasmussen Busund :
    Clinical Significance of Epidermal Growth Factor Receptors in Non-small Cell Lung Cancer and a Prognostic Role for HER2 Gene Copy Number in Female Patients
    Journal of Thoracic Oncology 2010 DOI
  • Tom Dønnem, Samer Al-Saad, Khalid Ibrahim Al-Shibli, Lill-Tove Rasmussen Busund, Roy M. Bremnes :
    Co-expression of PDGF-B and VEGFR-3 strongly correlates with lymph node metastasis and poor survival in non-small-cell lung cancer
    Annals of Oncology 2010 DOI
  • Tom Dønnem, Khalid Ibrahim Al-Shibli, Sigve Andersen, Samer Al-Saad, Lill-Tove Rasmussen Busund, Roy M. Bremnes :
    Combination of low vascular endothelial growth factor A (VEGF-A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor in patients with nonsmall cell lung cancer
    Cancer 2010 DOI
  • Khalid Ibrahim Al-Shibli, Samer Al-Saad, Sigve Andersen, Tom Dønnem, Roy M. Bremnes, Lill-Tove Rasmussen Busund :
    The prognostic value of intraepithelial and stromal CD3-, CD117-and CD138-positive cells in non-small cell lung carcinoma
    APMIS - Journal of Pathologiy, Microbiology and Immunology 2010 DOI
  • Tom Dønnem, Khalid Ibrahim Al-Shibli, Samer Al-Saad, Lill-Tove Rasmussen Busund, Roy M. Bremnes :
    Prognostic Impact of Fibroblast Growth Factor 2 in Non-small Cell Lung Cancer Coexpression with VEGFR-3 and PDGF-B Predicts Poor Survival
    Journal of Thoracic Oncology 2009
  • Sigve Andersen, Tom Dønnem, Samer Al-Saad, Khalid Ibrahim Al-Shibli, Lill-Tove Rasmussen Busund, Roy M. Bremnes :
    Angiogenic Markers Show High Prognostic Impact on Survival in Marginally Operable Non-small Cell Lung Cancer Patients Treated with Adjuvant Radiotherapy
    Journal of Thoracic Oncology 2009
  • Khalid Ibrahim Al-Shibli, Samer Al-Saad, Tom Dønnem, Magnus L. Persson, Roy M. Bremnes, Lill-Tove Rasmussen Busund :
    The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma
    Histopathology 2009 DOI
  • Tom Dønnem, Khalid Ibrahim Al-Shibli, Samer Al-Saad, Marit Pedersen Delghandi, Lill-Tove Rasmussen Busund, Roy M. Bremnes :
    VEGF-A and VEGFR-3 correlate with nodal status in operable non-small cell lung cancer: Inverse correlation between expression in tumor and stromal cells
    Lung Cancer 2009 DOI
  • Samer Al-Saad, Tom Dønnem, Khalid Ibrahim Al-Shibli, Magnus L. Persson, Roy M. Bremnes, Lill-Tove Rasmussen Busund :
    Diverse prognostic roles of Akt isoforms, PTEN and PI3K in tumor epithelial cells and stromal compartment in non-small cell lung cancer
    Anticancer Research 2009
  • Åslaug Helland, Hege Elisabeth Giercksky Russnes, Gro Live Fagereng, Khalid Ibrahim Al-Shibli, Yvonne Andersson, Thomas Berg m.fl.:
    Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway (Journal of Translational Medicine, (2022), 20, 1, (225), 10.1186/s12967-022-03432-5)
    Journal of Translational Medicine 2022 DOI
  • Åslaug Helland, Hege Elisabeth Giercksky Russnes, Gro Live Fagereng, Khalid Ibrahim Al-Shibli, Yvonne Andersson, Thomas Berg m.fl.:
    Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway
    Journal of Translational Medicine 14. mai 2022 ARKIV / FULLTEKST / DOI
  • Sigurd Hald, Yury Kiselev, Samer Al-Saad, Elin Helmine Richardsen, Charles Walquist Johannessen, Marte Eilertsen m.fl.:
    Erratum: Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: Combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival. [BMC Cancer. 15, (2015) (441)] DOI: 10.1186/s12885-015-1446-z
    BMC Cancer 2016 DOI
  • Sveinung Wergeland Sørbye, Thomas Karsten Kilvær, Andrey Yurjevich Valkov, Tom Dønnem, Eivind Smeland, Khalid Ibrahim Al-Shibli m.fl.:
    High expression of CD20+ lymphocytes in soft tissue sarcomas is a positive prognostic indicator
    Oncoimmunology 2012 ARKIV / DOI
  • Samer Al-Saad, Khalid Ibrahim Al-Shibli, Tom Dønnem, Sigve Andersen, Roy M. Bremnes, Lill-Tove Rasmussen Busund :
    Simultaneous Expression of EGFR, HER2, HER3 and HER4 in Non-Small Cell Lung Cancer NSCLC: Correlation With Clinical Outcome and a Comparison Between Immunohistochemical Protein Expression and Silver In Situ Hybridization (SISH) For Detection of HER2 Gene Amplification
    APMIS - Journal of Pathologiy, Microbiology and Immunology 2010
  • Sveinung Wergeland Sørbye, Andrey Yurjevich Valkov, T Kilvær, Tom Dønnem, E Smeland, Khalid Ibrahim Al-Shibli m.fl.:
    Prognostic impact of lymphocyte infiltration in tumor and capsule in soft tissue sarcomas
    APMIS - Journal of Pathologiy, Microbiology and Immunology 2010
  • Samer Al-Saad, Tom Dønnem, Khalid Ibrahim Al-Shibli, Magnus L. Persson, Roy M. Bremnes, Lill-Tove Rasmussen Busund :
    Diverse prognostic roles of Akt isoforms, PTEN and PI3K in tumor epithelial cells and stromal compartment in non-small cell lung cancer
    APMIS - Journal of Pathologiy, Microbiology and Immunology 2009
  • Sigve Andersen, Marte Eilertsen, Tom Dønnem, Samer Al-Saad, Khalid Ibrahim Al-Shibli, Lill-Tove Rasmussen Busund m.fl.:
    Diverging prognostic impacts of hypoxic markers in histologic non-small cell lung cancer (NSCLC) subtypes
    Journal of Thoracic Oncology 2009

  • De 50 siste resultatene fra Cristin vises på siden. Se alle arbeider i Cristin her →